Novartis
Ticker >

Novartis share price

Novartis India Ltd.

NSE: NOVARTIND BSE: 500672 SECTOR: Trading  20k   38   4

1055.10
+9.20 (0.88%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 1059.65

Today's Low

₹ 1044

52 Week High

₹ 1224

52 Week Low

₹ 585

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 2605.13 Cr.

Enterprise Value

₹ 2049.19 Cr.

No. of Shares

2.47 Cr.

P/E

27.27

P/B

3.57

Face Value

₹ 5

Div. Yield

4.5 %

Book Value (TTM)

₹  295.19

CASH

₹ 555.94 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

70.68 %

EPS (TTM)

₹  38.69

Sales Growth

-5.28%

ROE

14.07 %

ROCE

15.96%

Profit Growth

2878.49 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-5.28%
3 Year-4.75%
5 Year-7.65%

Profit Growth

1 Year2878.49%
3 Year117.25%
5 Year5.69%

ROE%

1 Year14.07%
3 Year5.48%
5 Year4.94%

ROCE %

1 Year15.96%
3 Year7.59%
5 Year7.84%

Debt/Equity

0

Price to Cash Flow

58.15

Interest Cover Ratio

66.9314285714286

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 70.68 0
Dec 2023 70.68 0
Sep 2023 70.68 0
Jun 2023 70.68 0
Mar 2023 70.68 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 117.252103201553% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 66.9314285714286.
  • Company’s PEG ratio is 0.00947382491485999.
  • The company has an efficient Cash Conversion Cycle of -42.9235928261754 days.
  • Company has a healthy liquidity position with current ratio of 2.93021695370163.
  • The company has a high promoter holding of 70.68%.

 Limitations

  • The company has shown a poor revenue growth of -4.74817736197044% for the Past 3 years.
  • Company has a poor ROE of 5.48144208459798% over the past 3 years.
  • Company has contingent liabilities of 419.25 Cr.
  • Tax rate is low at 10.4177500433351.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 80.17 76.13 90.6 78.76 84.54
Total Expenditure 72.53 66.81 73.28 61.85 64.77
Operating Profit 7.64 9.32 17.32 16.91 19.77
Other Income 8.36 16.37 12.47 16.88 21.96
Interest 0.46 0.3 0.46 0.71 0.16
Depreciation 1.3 2.08 1.56 0.65 0.26
Exceptional Items 0 0 0 0 0
Profit Before Tax 14.24 23.31 27.77 32.43 41.31
Tax 6.63 -1.71 7.51 8.75 14.74
Profit After Tax 7.61 25.02 20.26 23.68 26.57
Adjusted EPS (Rs) 3.08 10.14 8.21 9.59 10.77

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 490.68 438.25 381.35 399.87 378.74
Total Expenditure 478.54 426.51 355.66 373.12 313.66
Operating Profit 12.14 11.74 25.69 26.75 65.08
Other Income 78.4 36.43 34.19 33.55 58.11
Interest 1.59 6.39 7.68 4.83 1.75
Depreciation 3.18 13.14 12.16 9.65 6.06
Exceptional Items 0 0 0 -49.64 0
Profit Before Tax 85.77 28.64 40.04 -3.82 115.38
Tax 34 18.56 19.14 -0.1 12.02
Net Profit 51.77 10.08 20.9 -3.72 103.36
Adjusted EPS (Rs.) 20.98 4.08 8.47 -1.51 41.88

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 12.34 12.34 12.34 12.34 12.34
Total Reserves 746.85 708.39 698.85 679.36 763.32
Borrowings 0 0 0 0 0
Other N/C liabilities 891.47 99.38 1130.65 984 1007.77
Current liabilities 367.22 416.93 357.26 334.47 268.26
Total Liabilities 2017.88 1237.04 2199.1 2010.17 2051.69
Assets
Net Block 14.98 76.28 63.91 23.65 19.25
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 989.61 137.84 1186.01 1148.65 1240.75
Other N/C Assets 24.61 25.65 26.83 12 5.63
Current Assets 988.68 997.27 922.35 825.87 786.06
Total Assets 2017.88 1237.04 2199.1 2010.17 2051.69
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 85.77 28.64 40.04 -3.82 115.38
Adjustment -72.66 -11.8 -4.98 -5.64 -48.92
Changes in Assets & Liabilities -161.76 -1.85 -69.08 66.72 -24
Tax Paid -45.63 -38.13 -35.19 -18.59 2.34
Operating Cash Flow -194.28 -23.14 -69.21 38.67 44.8
Investing Cash Flow 274.23 55.91 95.16 87.04 -153.25
Financing Cash Flow -29.82 -41.41 -36.8 -35.63 -30.48
Net Cash Flow 50.13 -8.64 -10.85 90.08 -138.93

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 70.68 70.68 70.68 70.68 70.68
novartis ag 70.68 70.68 70.68 70.68 70.68
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 29.32 29.32 29.32 29.32 29.32
atul limited 1.52 1.52 1.52 1.52 1.52
investor education and pr... 0.58 0.58 0.64 0.64 0.63
llp 0.34 0.34 0.35 0.35 0.37

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Novartis India informs about details of loss of certificate 19 Mar 2024, 2:50PM Novartis India informs about loss of share certificate28 Feb 2024, 2:55PM Novartis India informs about loss of share certificate27 Feb 2024, 11:40AM Novartis India informs about loss of share certificate 17 Feb 2024, 12:35PM Novartis India informs about outcome of board meeting 17 Feb 2024, 11:05AM Novartis India informs about details of loss of certificate 9 Feb 2024, 5:04PM Novartis India informs about newspaper publication27 Jan 2024, 9:44AM Novartis - Quaterly Results25 Jan 2024, 2:55PM Novartis - Quaterly Results25 Jan 2024, 2:55PM Novartis - Quaterly Results25 Jan 2024, 2:55PM Novartis India informs about details of loss of certificate6 Jan 2024, 3:33PM Novartis India informs about loss of share certificate2 Jan 2024, 2:20PM Novartis India informs about issuance of duplicate share certificate21 Dec 2023, 4:52PM Novartis India informs about details of loss of certificate 13 Dec 2023, 12:53PM Novartis India informs about details of loss of certificate12 Dec 2023, 4:58PM Novartis India informs about details of loss of certificate25 Nov 2023, 3:21PM Novartis India informs about details of loss of certificate22 Nov 2023, 4:11PM Novartis - Quaterly Results27 Oct 2023, 3:12PM Novartis - Quaterly Results27 Oct 2023, 3:12PM Novartis - Quaterly Results27 Oct 2023, 3:12PM Novartis India informs about closure of trading window30 Sep 2023, 4:23PM Novartis India submits board meeting intimation 30 Sep 2023, 3:47PM Novartis India informs about loss of share certificate 20 Sep 2023, 2:28PM Novartis India informs about loss of share certificate 12 Sep 2023, 10:28AM Novartis India informs about loss of share certificate28 Aug 2023, 4:14PM Novartis India informs about loss of share certificate25 Aug 2023, 12:11PM Novartis India informs about loss of share certificates14 Aug 2023, 2:41PM Novartis India informs about details of loss of certificate11 Aug 2023, 1:50PM Novartis India informs about details of loss of certificate9 Aug 2023, 1:03PM Novartis - Quaterly Results26 Jul 2023, 2:52PM Novartis - Quaterly Results26 Jul 2023, 2:52PM Novartis - Quaterly Results26 Jul 2023, 2:52PM Novartis India informs about compliances-certificate 5 Jul 2023, 4:31PM Novartis India informs about loss of share certificate3 Jul 2023, 2:24PM Novartis India informs about loss of share certificates24 Jun 2023, 12:56PM Novartis India informs about newspaper publication 11 May 2023, 2:06PM Novartis - Quaterly Results10 May 2023, 5:42PM Novartis - Quaterly Results10 May 2023, 5:42PM Novartis India informs about loss of share certificate25 Apr 2023, 2:41PM Novartis India informs about loss of share certificate15 Mar 2023, 5:08PM Novartis India informs about loss of share certificate 8 Mar 2023, 3:27PM Novartis India informs about loss of share certificate14 Feb 2023, 5:30PM Novartis - Quaterly Results8 Feb 2023, 6:11PM Novartis - Quaterly Results8 Feb 2023, 6:11PM Novartis - Quaterly Results8 Feb 2023, 6:11PM Novartis India informs about loss of share certificate12 Jan 2023, 2:25PM Novartis India informs about issuance of duplicate share certificate5 Jan 2023, 4:47PM Novartis India informs about loss of share certificate24 Dec 2022, 4:13PM Novartis India informs about loss of share certificates15 Dec 2022, 11:35AM Novartis India informs about loss of share certificates14 Dec 2022, 10:15AM

Novartis Stock Price Analysis and Quick Research Report. Is Novartis an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Novartis has a PE ratio of 17.3750662307285 which is high and comparatively overvalued .

  • Share Price: - The current share price of Novartis is Rs 672.25. One can use valuation calculators of ticker to know if Novartis share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Novartis has ROA of 5.08929406724998 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Novartis has a Current ratio of 2.93021695370163 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Novartis has a ROE of 14.0662212000381 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Novartis has a D/E ratio of 0 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Novartis has an Inventory turnover ratio of 8.22721173629126 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Novartis has reported revenue growth of -5.28421737064545 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Novartis for the current financial year is 17.1832919681048 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Novartis is Rs 47.5 and the yield is 4.4839 %.

Last Updated on:
Brief about Novartis

Novartis India Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Novartis India Ltd. is a leading pharmaceutical company in India. It is a subsidiary of the global healthcare company Novartis AG. Novartis India has been operating in the country for several decades and has established itself as a trusted provider of high-quality medicines.

Novartis India Ltd. - Share Price

Stay updated with the latest share price of Novartis India Ltd. Our website provides real-time stock prices along with historical data. Our pre-built screening tools allow you to analyze the share price performance of Novartis India over different time periods.

Novartis India Ltd. - Balance Sheet

Access the balance sheet of Novartis India Ltd. on our website. Our premium features enable fair value calculation using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. These tools help long-term stock investors gain insights into the financial health of the company.

Novartis India Ltd. - Annual Report

Download the annual reports of Novartis India Ltd. from our website. The annual reports provide a comprehensive overview of the company's performance, financials, and strategic initiatives. They are valuable resources for investors to assess the company's long-term prospects.

Novartis India Ltd. - Dividend

Track the dividend history of Novartis India Ltd. on our website. Dividends are an important consideration for many investors looking for stable income from their investments. Novartis India regularly evaluates and announces dividends to reward its shareholders.

Novartis India Ltd. - Quarterly Results

Stay informed about the quarterly results of Novartis India Ltd. Our website provides access to the latest financial reports and insights from earnings calls. These reports help investors track the company's performance and make informed investment decisions.

Novartis India Ltd. - Stock Price

Analyze the stock price movement of Novartis India Ltd. on our website. Our pre-built screening tools and price charts allow investors to track the stock's historical performance and identify potential investment opportunities.

Novartis India Ltd. - Price Chart

Visualize the price chart of Novartis India Ltd. on our website. Price charts provide a graphical representation of the stock's price movement over time, helping investors spot trends, patterns, and potential support and resistance levels.

Novartis India Ltd. - News

Access the latest news updates about Novartis India Ltd. Our website provides a curated feed of news articles and press releases related to the company. Stay informed about the latest developments that may impact your investment decisions.

Novartis India Ltd. - Concall Transcripts

Download the concall transcripts of Novartis India Ltd. from our website. Concall transcripts are valuable resources that provide insights into the company's performance, management commentary, and future outlook as discussed during the earnings calls.

Novartis India Ltd. - Investor Presentations

Find investor presentations of Novartis India Ltd. on our website. Investor presentations offer a comprehensive overview of the company's strategy, financials, and operational highlights. These presentations are useful for investors to understand the company's business and investment potential.

Novartis India Ltd. - Promoters

Learn about the promoters of Novartis India Ltd. Promoters play a crucial role in the company's management and decision-making process. Our website provides information about the promoters and their contribution to the company's growth.

Novartis India Ltd. - Shareholders

Explore information about the shareholders of Novartis India Ltd. Shareholders play a significant role in the company's ownership and governance. Our website provides insights into the major shareholders of Novartis India and their stake in the company.

By providing comprehensive stock analysis tools, access to key financial reports, and curated news updates, our website aims to empower long-term stock investors in making informed decisions regarding Novartis India Ltd. Stay updated with the latest information and leverage our premium features for fair value calculations and in-depth analysis.

Read More
X